Axogen Inc vs Microsoft — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while Microsoft trades at $389.86 (market cap $2.86T). The key difference: Microsoft is far larger — about 1388.3× Axogen Inc's market cap, and Microsoft pays a 0.95% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | MSFT | |
|---|---|---|
Market Cap | $2.06B | $2.86T |
Sector | Technology | Technology |
52-Week High | $46.19 | $542.07 |
52-Week Low | $11.28 | $352.83 |
Enterprise Value | $1.98B | $2.84T |
Volume | — | 36,654,621 |
Dividend Yield | — | 0.95% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Microsoft (MSFT) trades at $390.99, up 1.53% over the past day, with a neutral technical signal and strong fundamentals. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.27 exceeding the $4.06 estimate. Revenue growth remains solid, reaching $281.72 billion in 2025, while profit margins are healthy at 39.34%. Analyst consensus is overwhelmingly bullish with an 80.49% buy rating and a $551.62 price target.
Outlook: MSFT's leadership in AI and cloud computing, coupled with consistent earnings outperformance, supports long-term growth. Risks include elevated capital expenditure concerns and competitive pressures. The stock presents a compelling opportunity for investors seeking exposure to a financially strong tech giant, though market volatility and geopolitical factors warrant caution.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →